Nanozyme-catalyzed dual-potential electrochemiluminescence immunosensor for simultaneous detection of CEA and NSE as lung cancer biomarkers.
A nanozyme-catalyzed dual-potential electrochemiluminescence (ECL) immunosensor was described for the simultaneous detection of lung cancer biomarkers: carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE).